World Stroke Day Research Spotlight: A significant leap forward in targeted drug delivery for stroke patients

This just proves the COMPLETE FUCKING INCOMPENCE OF STROKE LEADERSHIP! It took over 9 years to get from first research concept to actual product.

• magnetic nanoparticles (12 posts to September 2016)

You mean stroke leadership completely fucking failed at putting together magnetic nanoparticles delivering smaller loads of tPA resulting in much less chance of bleeds? Solving doctor reluctance.

We should have been using magnetic nanoparticles to deliver tPA for years.

Maybe this solution from March, 2015

Magnetic nanoparticles could stop blood clot-caused strokes

Or this from May, 2012

Future of med devices: Nanorobots in your blood stream

The latest here:

World Stroke Day Research Spotlight: A significant leap forward in targeted drug delivery for stroke patients

On World Stroke Day, we are bringing attention to two groundbreaking European stroke research projects. One of these, the ANGIE project, funded by the EU Horizon 2020 programme, focuses on an innovative approach to treating ischemic strokes—strokes caused by blood clots that block blood flow to the brain. 

Current treatments, like the drug rtPA, dissolve clots but must be administered in large doses, increasing the risk of dangerous side effects. To address this, researchers, led by Principal Investigator Professor Salvador Panè, developed tiny dissolvable microrobots that can be guided through blood vessels using magnetic fields. These microrobots deliver the drug directly to the clot, making treatment more precise and reducing risks. 

“This is a significant leap forward in targeted drug delivery,” said Professor Panè, while Arlene Wilkie, Director General of the Stroke Alliance for Europe, added, “We look forward to seeing this technology transform stroke care and improve patient outcomes.” 

This breakthrough offers hope for more effective and safer stroke treatments, potentially improving recovery rates and reducing long-term complications.

Learn more in this video

 

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 952152. 

More information can be found at www.h2020-angie.eu